TURNOVER (x1000 SEK)
Loading chart. Please wait
NET PROFIT (x1000 SEK)
Loading chart. Please wait
EMPLOYEES
Loading chart. Please wait
Bluefish Pharmaceuticals AB (publ)
Closing information (x1000 SEK)
| Closing information | 2023/04 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
540,097
|
385,500
|
414,418 |
| Financial expenses |
41,154
|
15,398
|
8,551 |
| Earnings before taxes |
-90,170
|
-18,974
|
36,002 |
| EBITDA |
-27,543
|
17,604 | |
| Total assets |
540,718
|
568,148
|
501,818 |
| Current assets |
411,429
|
457,885
|
371,769 |
| Current liabilities |
202,590
|
457,003
|
211,995 |
| Equity capital |
-41,649
|
88,697
|
108,167 |
| - share capital |
21,584
|
21,584
|
21,584 |
| Employees (average) |
128
|
124
|
129 |
Financial ratios
| Fiscal year | 2023/04 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
-7.7%
|
15.6%
|
21.6% |
| Turnover per employee |
4,220
|
3,109
|
3,213 |
| Profit as a percentage of turnover |
-16.7%
|
-4.9%
|
8.7% |
| Return on assets (ROA) |
-9.1%
|
-0.6%
|
8.9% |
| Current ratio |
203.1%
|
100.2%
|
175.4% |
| Return on equity (ROE) |
216.5%
|
-21.4%
|
33.3% |
| Change turnover |
154,597
|
-28,918
|
34,521 |
| Change turnover % |
40%
|
-7%
|
9% |
| Chg. No. of employees |
4
|
-5
|
-20 |
| Chg. No. of employees % |
3%
|
-4%
|
-13% |
Total value of public sale
| Fiscal year | 2023/04 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.